These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1544 related articles for article (PubMed ID: 20569652)

  • 1. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.
    Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D
    Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
    McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
    Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A danish healthcare-focused economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation.
    Hansen ML; Moss JWE; Tønnesen J; Johansen ML; Kuniss M; Ismyrloglou E; Andrade J; Wazni O; Mealing S; Sale A; Afonso D; Bromilow T; Lane E; Chierchia GB
    BMC Cardiovasc Disord; 2024 Jul; 24(1):363. PubMed ID: 39014312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.
    Buxton M; Caine N; Chase D; Connelly D; Grace A; Jackson C; Parkes J; Sharples L
    Health Technol Assess; 2006 Aug; 10(27):iii-iv, ix-xi, 1-164. PubMed ID: 16904046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from an English National Health Service perspective.
    Paisey J; Moss J; Andrade J; Kuniss M; Wazni O; Chierchia GB; Mealing S; Ismyrloglou E; Sale A; Souter M; Kaplon R; Bromilow T; Lane E; Lewis D; Todd D
    Open Heart; 2024 Jan; 11(1):. PubMed ID: 38238026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cost-Effectiveness of First-Line Cryoablation vs First-Line Antiarrhythmic Drugs in Canadian Patients With Paroxysmal Atrial Fibrillation.
    Andrade JG; Moss JWE; Kuniss M; Sadri H; Wazni O; Sale A; Ismyrloglou E; Chierchia GB; Kaplon R; Mealing S; Bainbridge J; Bromilow T; Lane E; Khaykin Y
    Can J Cardiol; 2024 Apr; 40(4):576-584. PubMed ID: 38007219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness and cost-effectiveness of dual-chamber pacemakers compared with single-chamber pacemakers for bradycardia due to atrioventricular block or sick sinus syndrome: systematic review and economic evaluation.
    Castelnuovo E; Stein K; Pitt M; Garside R; Payne E
    Health Technol Assess; 2005 Nov; 9(43):iii, xi-xiii, 1-246. PubMed ID: 16266560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of rate control versus rhythm control for management of atrial fibrillation in patients with coexisting heart failure: a cost-effectiveness analysis.
    Perez A; Touchette DR; DiDomenico RJ; Stamos TD; Walton SM
    Pharmacotherapy; 2011 Jun; 31(6):552-65. PubMed ID: 21923439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
    Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
    Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dronedarone for the treatment of atrial fibrillation and atrial flutter.
    Maund E; McKenna C; Sarowar M; Fox D; Stevenson M; Pepper C; Palmer S; Woolacott N
    Health Technol Assess; 2010 Oct; 14(Suppl. 2):55-62. PubMed ID: 21047492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety and effectiveness of different methods of earwax removal: a systematic review and economic evaluation.
    Clegg AJ; Loveman E; Gospodarevskaya E; Harris P; Bird A; Bryant J; Scott DA; Davidson P; Little P; Coppin R
    Health Technol Assess; 2010 Jun; 14(28):1-192. PubMed ID: 20546687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost-effectiveness of testing for hepatitis C in former injecting drug users.
    Castelnuovo E; Thompson-Coon J; Pitt M; Cramp M; Siebert U; Price A; Stein K
    Health Technol Assess; 2006 Sep; 10(32):iii-iv, ix-xii, 1-93. PubMed ID: 16948891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic surgery for inguinal hernia repair: systematic review of effectiveness and economic evaluation.
    McCormack K; Wake B; Perez J; Fraser C; Cook J; McIntosh E; Vale L; Grant A
    Health Technol Assess; 2005 Apr; 9(14):1-203, iii-iv. PubMed ID: 15842951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling.
    Connock M; Stevens C; Fry-Smith A; Jowett S; Fitzmaurice D; Moore D; Song F
    Health Technol Assess; 2007 Oct; 11(38):iii-iv, ix-66. PubMed ID: 17903392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dronedarone for the treatment of atrial fibrillation: a NICE single technology appraisal.
    McKenna C; Maund E; Sarowar M; Fox D; Stevenson M; Pepper C; Woolacott N; Palmer S
    Pharmacoeconomics; 2012 Jan; 30(1):35-46. PubMed ID: 22136303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.
    Connock M; Burls A; Frew E; Fry-Smith A; Juarez-Garcia A; McCabe C; Wailoo A; Abrams K; Cooper N; Sutton A; O'Hagan A; Moore D
    Health Technol Assess; 2006 Jul; 10(24):iii-iv, ix-136. PubMed ID: 16796930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of alternative strategies for the initial medical management of non-ST elevation acute coronary syndrome: systematic review and decision-analytical modelling.
    Robinson M; Palmer S; Sculpher M; Philips Z; Ginnelly L; Bowens A; Golder S; Alfakih K; Bakhai A; Packham C; Cooper N; Abrams K; Eastwood A; Pearman A; Flather M; Gray D; Hall A
    Health Technol Assess; 2005 Jul; 9(27):iii-iv, ix-xi, 1-158. PubMed ID: 16022802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review and economic model of the clinical and cost-effectiveness of immunosuppressive therapy for renal transplantation in children.
    Yao G; Albon E; Adi Y; Milford D; Bayliss S; Ready A; Raftery J; Taylor RS
    Health Technol Assess; 2006 Dec; 10(49):iii-iv, ix-xi, 1-157. PubMed ID: 17134597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lead-I ECG for detecting atrial fibrillation in patients with an irregular pulse using single time point testing: a systematic review and economic evaluation.
    Duarte R; Stainthorpe A; Greenhalgh J; Richardson M; Nevitt S; Mahon J; Kotas E; Boland A; Thom H; Marshall T; Hall M; Takwoingi Y
    Health Technol Assess; 2020 Jan; 24(3):1-164. PubMed ID: 31933471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 78.